Lithium Africa Resources Corp. Announces $6M Equity Financing and Intention to Complete a Listing on a Canadian Stock Exchange
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES LISBON, Portugal, Feb. 10, 2025 /PRNewswire/ -- Lithium Africa Resources Corp. ("Lithium Africa" or the "Company") is pleased to announce that...
BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- On December 19, 2024, BioRay Pharmaceutical Co., Ltd. ("BioRay") announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed Class 1...
2025 Singclean Global Aesthetic Master Symposium Debuted in France
PARIS, Feb. 10, 2025 /PRNewswire/ -- 2025 IMCAS World Congress, the world's largest scientific aesthetics congress, was grandly held in Paris from January 30 to February 1, celebrating its 26th anniversary. SINGCLEAN highlight video in IMCAS 2025...
TPIsoftware Partners with Lissome to Transform Tainan Cultural Site with AI and Green Energy Technologies
TAIPEI, Feb. 10, 2025 /PRNewswire/ -- TPIsoftware (TWSE: 7781) and Lissome Arts and Culture Co., Ltd. have announced a collaboration to rejuvenate a historic cultural site in Tainan's North District, a designated area near the established cultural...
ZK International Postpones Shareholder Call
WENZHOU, China, Feb. 8, 2025 /PRNewswire/ -- ZK International Group Co., Ltd. (Nasdaq: ZKIN) (" ZK International" or the "Company"), a leading engineering Company focused on high-performance steel products, announces that its previously scheduled...
Cellid Raises $13 Million to Advance AR Glasses Display Development
Advancing Adoption through Enhanced Mass Production and Accelerated Product Launches TOKYO, Feb. 6, 2025 /PRNewswire/ -- Cellid Inc., a developer of AR glasses displays and spatial recognition engines for next-generation devices, today announced...
Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer
SUZHOU, China, Feb. 6, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has...
![Expanding Expertise in Energy: SMART ENERGY WEEK [February] 2025 reveals conference lineup & new exhibit area](http://prnewswire.vietreader.com/thumb/190x300/2025-02/expanding-expertise-in-energy-smart-energy-week-february-2025-reveals-conference-lineup-new-exhibit-area-1.jpg)
Expanding Expertise in Energy: SMART ENERGY WEEK [February] 2025 reveals conference lineup & new exhibit area
TOKYO, Feb. 6, 2025 /PRNewswire/ -- With its strong belief in the role of renewable energy towards a progressive future, SMART ENERGY WEEK [February] continues to enrich industry expertise with the launch of its much-awaited conference programme for...
Polyplastics to Launch 40% Glass-filled Recycled DURAFIDE (R) PPS Based on New Post-industrial Recycling System
TOKYO, Feb. 5, 2025 /PRNewswire/ -- Polyplastics Co., Ltd., a global leader in engineering plastics, has announced plans to launch a 40% glass-reinforced grade of DURAFIDE (R) rG-PPS by December 2025 as part of its mechanical recycling business. The...
Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 5, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...